NCT01057615

Brief Summary

Combining fish oil and vitamin C supplementation will provide a greater anti-inflammatory effect against developing exercise-induced bronchoconstriction (EIB) than either nutritional supplement alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for phase_1 asthma

Timeline
Completed

Started Mar 2010

Typical duration for phase_1 asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 27, 2010

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

January 31, 2011

Status Verified

January 1, 2011

Enrollment Period

9 months

First QC Date

January 26, 2010

Last Update Submit

January 28, 2011

Conditions

Keywords

AsthmaExercise-Induced BronchoconstrictionInflammationAirwayFish OilAscorbic Acid

Outcome Measures

Primary Outcomes (1)

  • Pulmonary Function

    8 weeks

Secondary Outcomes (1)

  • Exhaled nitric oxide to measure airway inflammation

    8 weeks

Study Arms (3)

Active Fish Oil + Vitamin C Placebo

EXPERIMENTAL

Fifteen subjects will take 10 active fish oil capsules per day and 2 vitamin C placebo capsules per day for 3 weeks.

Dietary Supplement: Fish OilDietary Supplement: Ascorbic Acid Placebo

Fish Oil Placebo + Active Vitamin C

EXPERIMENTAL

Fifteen subjects will take 10 fish oil placebo capsules per day and 2 active vitamin C capsules per day for 3 weeks.

Dietary Supplement: Ascorbic AcidDietary Supplement: Fish Oil Placebo

Active Fish Oil + Active Vitamin C

EXPERIMENTAL

Following a 2-week washout period, all subjects from the other two arms (n=30) will take 10 active fish oil capsules per day and 2 active vitamin C capsules per day for 3 weeks.

Dietary Supplement: Fish OilDietary Supplement: Ascorbic Acid

Interventions

Fish OilDIETARY_SUPPLEMENT

10 fish oil (3.2g EPA + 2.0g DHA) capsules per day for 3 weeks

Active Fish Oil + Active Vitamin CActive Fish Oil + Vitamin C Placebo
Ascorbic AcidDIETARY_SUPPLEMENT

2 pharmaceutical grade ascorbic acid (1500mg) capsules per day for 3 weeks

Also known as: Vitamin C
Active Fish Oil + Active Vitamin CFish Oil Placebo + Active Vitamin C
Fish Oil PlaceboDIETARY_SUPPLEMENT

10 placebo fish oil (soy bean oil) capsules per day for 3 weeks

Also known as: Soy Bean Oil
Fish Oil Placebo + Active Vitamin C
Ascorbic Acid PlaceboDIETARY_SUPPLEMENT

2 placebo ascorbic acid (sucrose) capsules per day for 3 weeks

Also known as: Table Sugar
Active Fish Oil + Vitamin C Placebo

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of asthma, based on medication use as well as history and symptoms as outlined in the NHLBI Guidelines for the Diagnosis and Management of Asthma
  • Diagnosis of EIB, based on ≥10% fall in post-challenge FEV1, a measure of lung function, after dry air eucapnic voluntary hyperventilation (EVH), a simulated exercise challenge
  • Not currently taking asthma maintenance medication or physician approval to discontinue current asthma medication for the duration of the study
  • Not currently taking any fish oil or ascorbic acid supplements above the level recommended for adequate intake (if currently taking supplements, can participate if the subject stops taking the supplements for 2 weeks before starting the study and throughout the study)
  • Agree to limit fish consumption to 1 fish meal per week throughout the study
  • Agree to avoid vitamin C-rich foods throughout the study

You may not qualify if:

  • Resting FEV1 (the amount of air blown out in the first second of a forced exhalation) \<60% of predicted when off medication
  • Pregnancy
  • History of cardiovascular disease, including hyperlipidemia (high cholesterol) and hypertension (high blood pressure)
  • History of bleeding disorders or delayed clotting time
  • History of diabetes
  • History of seizures
  • Allergy to fish oil or ascorbic acid (vitamin C)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University

Bloomington, Indiana, 47405, United States

Location

Related Publications (3)

  • Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003 Nov 15;168(10):1181-9. doi: 10.1164/rccm.200303-373OC. Epub 2003 Aug 6.

    PMID: 12904324BACKGROUND
  • Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006 Jan;129(1):39-49. doi: 10.1378/chest.129.1.39.

    PMID: 16424411BACKGROUND
  • Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med. 2007 Aug;101(8):1770-8. doi: 10.1016/j.rmed.2007.02.014. Epub 2007 Apr 5.

    PMID: 17412579BACKGROUND

MeSH Terms

Conditions

AsthmaInflammation

Interventions

Fish OilsAscorbic AcidSoybean OilDietary Sucrose

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

OilsLipidsSugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydratesDietary Fats, UnsaturatedDietary FatsFatsFats, UnsaturatedPlant OilsPlant PreparationsBiological ProductsComplex MixturesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesDietary SugarsDietary CarbohydratesSucroseDisaccharidesOligosaccharidesPolysaccharidesSugarsNutritive SweetenersSweetening AgentsFlavoring AgentsFood AdditivesFood IngredientsSpecialty Uses of ChemicalsChemical Actions and Uses

Study Officials

  • Timothy D Mickleborough, PhD

    Indiana University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 26, 2010

First Posted

January 27, 2010

Study Start

March 1, 2010

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

January 31, 2011

Record last verified: 2011-01

Locations